Clinical trial
The Prevalence of ATTR Cardiac Amyloidosis in Elderly Middle Eastern Patients Undergoing Transarterial Aortic Valve Replacement
NCT06015997 is registered in ClinicalTrials.gov with Jordan Collaborating Cardiology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Prevalence of ATTR Cardiac Amyloidosis in Elderly Middle Eastern Patients Undergoing Transarterial Aortic Valve Replacement
- Lead sponsor
- Jordan Collaborating Cardiology Group
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2023
- Completion date
- November 1, 2025
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve stenosis, attr amyloidosis wild type, middle east studies, severe aortic stenosis